
Molecule: USTEKINUMAB
ChEMBL ID: CHEMBL1201835
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2009

Molecule: BRIAKINUMAB
ChEMBL ID: CHEMBL1742995
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: EBDAROKIMAB
ChEMBL ID: CHEMBL4650437
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: USTEKINUMAB
ChEMBL ID: CHEMBL1201835
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2009

Molecule: BRIAKINUMAB
ChEMBL ID: CHEMBL1742995
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: GUSELKUMAB
ChEMBL ID: CHEMBL2364648
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2017

Molecule: TILDRAKIZUMAB
ChEMBL ID: CHEMBL2108681
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2018

Molecule: BRAZIKUMAB
ChEMBL ID: CHEMBL3833372
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: RISANKIZUMAB
ChEMBL ID: CHEMBL3990029
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2019

Molecule: MIRIKIZUMAB
ChEMBL ID: CHEMBL3990014
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2023

Molecule: EBDAROKIMAB
ChEMBL ID: CHEMBL4650437
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
